Items Tagged ‘#Dr. Megan Allyse’
March 19, 2019
Not the end of the road: Delivering the diagnosis of sex-chromosome trisomy
Even if you’ve never heard the word “trisomy,” you probably know someone with the condition. March is Trisomy Awareness Month, a time to raise awareness about trisomy conditions and the challenges they can pose to individuals and families. Trisomy means having three copies of a chromosome instead of two. Down syndrome, or trisomy 21, is […]
Tags: #Down syndrome, #Dr. Megan Allyse, #Klinefelter syndrome, #sex-chromosomes, #trisomy, Mayo Clinic Center for Individualized Medicine
September 24, 2018
CIM CON — What is the impact on health care of genome editing?
Although Mayo Clinic does not use genome editing as part of any treatment in the medical practice, genome editing has promise for treating and even curing previously intractable disorders, such as Duchenne muscular dystrophy. Genome editing, via methods like CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats and CRISPR-associated protein) can be used to facilitate the […]
Tags: #CIMCon18, #CRISPR-Cas9, #Dr. Megan Allyse, #Dr. Shondra Pruett-Miller, #Dr. Stephen Tsang, #duchenne muscular dystrophy, #gene therapy, center for individualized medicine, gene editing, genomics, mayo clinic
July 16, 2018
Bioethics in the Cinema Program celebrates our WONDERful differences
By Sharon Rosen 
For many young children, the first day of the school year is filled with excitement. But for August (Auggie) Pullman and his parents, the first day of fifth grade at a public school is an anxious time. That’s because Auggie has facial differences from a genetic condition called Treacher Collins syndrome and has always been […]
Tags: #Bioethics at the Cinema, #Dr. Megan Allyse, #genetic disorders, #Mayo Clinic Biomedical Ethics Research Program, #Rochester Public Library, #Wonder, Bioethics, mayo clinic, Mayo Clinic Center for Individualized Medicine
April 10, 2018
Celebrating 15 years of advances in genomics: a time to reflect and look forward
By Sharon Rosen
DNA sequencing and genetic testing have changed medical practice by speeding diagnosis of rare diseases for which patients have visited many different medical providers in search of answers, offering new options in prenatal testing and ushering in a new era of individualized medicine. Genomics moved to the forefront of several areas of medicine after completion […]
Tags: #15 for 15 Celebration, #cell-free DNA testing, #CIMCon18, #DNA sequencing tests, #Dr. Megan Allyse, #Dr. Myra Wick, #expanded carrier screening, #prenatal testing, #rare and undiagnosed diseases, #rare diseases, #rare genetic diseases, #reproductive health
January 29, 2018
Direct-to-consumer genetic testing–a rapidly shifting landscape
Direct-to-consumer genetic or over the counter testing emerged in the early 2000s as a means of allowing consumers to access information about their genetics without the involvement of a physician. While early models were popular with consumers, they were controversial in medical and regulatory circles. In the January 2018 issue of Mayo Clinic Proceedings authors […]
Tags: #David Robinson, #DNA analysis, #Dr. Megan Allyse, #DTC genomic tests, #medical education, #Symposium on Precision Medicine, Bioethics, biomedical ethics, center for individualized medicine, Dr. Matthew Ferber, Dr. Richard Sharp, mayo clinic
December 12, 2017
4 key things to know about the possibilities, pitfalls of gene editing
ROCHESTER, Minn. — Gene editing has captivated scientists and medical providers with tantalizing visions of wiping out debilitating inherited diseases. Could conditions like Huntington’s disease, for example, be cured by using a tool that acts as a “molecular scissors” to remove and replace disease-causing DNA? Or, would gene editing tempt some to engineer designer babies […]
Tags: #CRISPR-Cas9, #Dr. Megan Allyse, #Genetic diseases, #Inherited disease, Bioethics, gene editing, mayo clinic, Mayo Clinic Center for Individualized Medicine
August 29, 2017
Exploring ethical issues to improve reproductive health
By Sharon Rosen
New genomic technologies offer great promise for better diagnostic tests and treatments for many conditions. But they also pose new ethical questions – ones physicians and patients must address when making decisions about medical care. For example, genetic tests can determine if a couple is at risk of having a child with a genetic condition. […]
Tags: #Center for Individualized Medicine Bioethics Program, #CIMCon17, #developmental pediatric services, #Down syndrome, #Dr. Megan Allyse, #Genetic diseases, #genetic disorders, #Genomic analysis, #Individualizing Medicine 2017, #Klinefelter syndrome, #perinatal testing, #prenatal genetic testing